Recent Headlines
Within Chemical Manufacturing
Global Vision Takes Automated Proofreading Solutions to PharmaPack, Paris
Global Vision, the leader in automated proofreading solutions for the pharmaceutical industry, will be demonstrating its content verification capabilities at PharmPack, Paris, February 6-7, 2008. Located at booth F04, Global Vision will be giving live demonstrations on how their solutions can... - January 22, 2008 - Global Vision
Improve Quality of Life with Supplement Targeting Hypothyroidism
Mitamins launches a formula by Dr. Balch that is specified to target Hypothyroidism. It contains Vitamins A, C, D, E, K, B-6, and B-12, as well as the nutrients Calcium, Iodine, Magnesium, Thiamin, Riboflavin, Niacin, Folate, Biotin, Copper, Selenium, Maganese, Chromium, Potassium, Pantothenic... - January 21, 2008 - Mitamins Inc.
Relief from Tinnitus
Dr. Balch has launched a Mitamins supplement designed to target Tinnitus. This supplement contains Vitamins B-12 and B-6, as well as the nutrients Thiamin, Riboflavin, Niacin, Folate, Biotin, Magnesium, Zinc, Copper, and Pantothenic Acid. It also includes Choline Bitartrate, Inositol, PABA, and Gingko Extract. - January 21, 2008 - Mitamins Inc.
Defeat Narcolepsy the Natural Way
Mitamins launches a new formula from Dr. Balch that is specified to target Narcolepsy. This supplement contains a complete spectrum of B vitamins, which are especially nourishing to the brain: Thiamin, Riboflavin, Niacin, Vitamin B12, Folate, Pantothenic Acid and Vitamin B6. The formula also includes an Amino Acid Mix, as well as L-Tyrosine, L-Glutamine, Lecithin and Ginkgo Extract. Necessary minerals such as Calcium, Magnesium and Chromium are included as well. - January 21, 2008 - Mitamins Inc.
Supplement for Emphysema: Enhance and Support Lung Health
From Sunnyvale, California - At Mitamins, a new supplement formula from Dr. Balch, which is targeted at Emphysema has been launched. This natural emphysema formula is focused on lung system recovery and repair. Botanicals such as Ginkgo Biloba, used to help with peripheral circulation, are included alongside powerful immunity-enhancing components such as Astragalus. Smoking- and stress-related nutritional deficiencies are addressed with a variety of essentials. - January 21, 2008 - Mitamins Inc.
Calcium Supplementation and Heart Attack Risk? Vitamin K2 May be a Solution.
Industry expert Scott Rosenbush strongly recommends vitamin K2 supplementation to help ensure bone and heart health. As the most bioactive and longest lasting form of vitamin K, menaquinone-7 is ideal for dietary supplements and functional foods. - January 19, 2008 - P.L. Thomas & Co., Inc.
Freelin-Wade Announces Launch of All-New Website
Freelin-Wade announced today the launch of their all-new Website. The site features an all new design, with functionality that has not been seen in the plastic tubing industry before. - January 15, 2008 - Freelin-Wade Company
Trevigen Launches Cultrex BME PathClear
Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc.
Vamoose® Second Hand Smoke Odors
Vamoose Products today announced their entry into the consumer odor elimination market with new products and consumer product packaging. Vamoose®, a tar and nicotine eliminator made up of an environmentally friendly formulation patented and trademarked as Novexium®, has been available to commercial clients for years. - January 10, 2008 - Hill Country Distribution
Refresh Your Auto – Remove Tobacco Odors Permanently with Vamoose® in New Car Scent
Vamoose Tobacco Odors and Smell Like a New Car. Vamoose®, which permanently removes the odors left by cigarettes and other tobacco products by molecularly combining with tar and nicotine molecules, is now available in a specially formulated New Car scent for auto’s, trucks, recreational... - January 09, 2008 - Hill Country Distribution
Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug
Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan... - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals
AnaSpec Introduces Ten New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals
EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals
‘Harsh Goenka Takes a Keen Note of Suchitra Krishnamurty’s Arty Comments’
The annual art camp by the RPG Academy of Art concluded with a warm brunch at the Marve beach house today. Pristine white was the theme of the locale and the breezy touch of sea winds along with the live band playing some groovy numbers got the enchantment heightened. After the week-long camp, the... - December 30, 2007 - RPG
Midbrook, Inc. Announces Partnership with Italian Leader in Solvent Cleaning
Midbrook, the minority owned provider of aqueous cleaning systems, is now the exclusive North American distributor and service agent for Firbimatic’s hermetically sealed solvent cleaning systems. Through this distributorship, Midbrook Inc. now provides a choice when water based systems do not provide the level of cleanliness necessary for parts cleaning. - December 29, 2007 - Midbrook Cleaning Systems
Midbrook, Inc. Will Build 12 New Washers for a Domestic Automobile Manufacturer with Plants in Mexico
Midbrook, Inc., of Jackson, Michigan, announced that it has been awarded a contract to build 12 new washers for a domestic based automotive company. These cleaning systems will be used as part of a new 6-speed transmission program. The equipment will be installed in a transmission plant located in Mexico. - December 29, 2007 - Midbrook Cleaning Systems
Miracle Drywash Waterless Valeting Kit for the Professional Car Enthusiast Now Available Online
SJK Products announces its waterless detailing car cleaning kit just in time for Christmas with a Buy-3-Get-a-4th-Kit-Free Christmas special offer. - December 24, 2007 - SJK Products Ltd
AnaSpec Introduces Sixteen New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit
AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group
Survey Verifies Link Between Nurses' Illness and Occupational Exposure
Scientists recently released the results of the first ever national survey which assessed nurses’ extent and frequency of exposures to common health care hazards. - December 19, 2007 - Carmel Pharma
2008: The Year of the Gnu?
A “Gnu” movement is taking hold across the country. People everywhere are chanting, “I want my fiber”. Dietary fiber, that is. People nationwide are proclaiming that the delicious Flavor & Fiber Bars, made by Gnu Foods, are the inspiration for their fiber-obsession. They... - December 18, 2007 - Gnu Foods, LLC
EPDM Coatings Releases Roofing Blog
EPDM Coatings LLC has launched and added a customized roof repair blog to its website. - December 16, 2007 - epdm coatings
AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 10 New Catalog Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group
AnaSpec Releases New Antibodies Brochure
With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group
Cardiovascular Sciences, Inc. Announces Funding Event
Cardiovascular Sciences, Inc. (CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead... - December 12, 2007 - Cardiovascular Sciences, Inc.
Professional Plastics, Inc. - Opens New Singapore Facility
Professional Plastics recently opened a new Singapore warehouse and distribution center to support their customers throughout Asia. The Singapore sales office and distribution center maintains a comprehensive inventory of plastic sheets, rods, tubing and films. Stock materials include: Torlon, Vespel, Meldin, Ultem, PEEK, Techtron PPS, Semitron ESd, Macor ceramic and more. - December 12, 2007 - Professional Plastics, Inc.
Granite Shield Gets a Home Sold in a Tough Market
Full service cleaning and restoration services including natural stone sealing, stain removal, marble polishing, grout and tile cleaning - December 10, 2007 - Granite Shield
First Laboratory Proven Naturopathic Antifungal Now Available to Fight Candida and Other Yeast and Yeast-Like Organisms
Candidacidin is the first naturopathic defense against yeast (Candida) which has been laboratory proven. Candida is now the fourth most prevalent organism found in bloodstream infections. Laboratory results validating antifungal properties are available on line. - December 08, 2007 - Florida Institute of Yeast
AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Collection of Bcl Peptides
AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 17 New Anti-Tau Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group
Carmel Pharma Introduces the Next Evolution of PhaSeal
Today, Carmel Pharma, Inc. introduces the Injector Luer Lock N35 with ErgoMotion™ during the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV. - December 03, 2007 - Carmel Pharma
KEC International Bags Two New Projects Worth Rs. 400 Crores
•Rs. 260 Crores Turnkey contract in Saudi Arabia •Rs. 140 Crores Turnkey contract in Namibia - December 01, 2007 - RPG
KEC International Bags Two New Projects Worth Rs. 637 Crores
•Rs. 391 Crores win in Abu Dhabi; Largest single win ever, in dollar value terms, for KEC •Rs. 246 crores turnkey contract in Algeria - December 01, 2007 - RPG
Be Nice, De-Ice: Xynyth Manufacturing Corp. Partners with Canada Post in Winter Safety Campaign
Xynyth Manufacturing Corp. partners with Canada Post and North Shore News in winter safety campaign. - November 29, 2007 - Xynyth Manufacturing Corp.
AnaSpec Celebrates the Holidays with Its Customers
AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces AnaTagTM Protein Labeling Kits with HiLytePlusTM
AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, EGT Group
Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit
In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals
Vamoose® Odor Remover Completely Removes Second-Hand Tobacco Odors from Cigarettes, Pipes and Cigars
Tobacco Odor Eliminator – Vamoose - Removes Smells and Stains at the Molecular Level - Now Available in Service Kits - November 18, 2007 - Hill Country Distribution
AnaSpec Introduces HiLytePlus™ Labeled Secondary Antibodies & Streptavidin
AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, EGT Group
New Capabilities Brochure Available from Thermal Spray Coating Firm
Advanced technology for applying protective coatings to industrial parts and products described in Pennsylvania firm's new literature - November 17, 2007 - Longevity Coatings
Autumn Graphics Selects Global Vision
Autumn Graphics, a prepress house specializing in a wide range of packaging graphics called on Global Vision, the leader in delivering automated inspection solutions, to help them ensure the accuracy of their production files during the inspection process. Handling all the artwork inspections... - November 12, 2007 - Global Vision